REGULATION OF AUTOPROTEOLYSIS OF THE HIV-1 AND HIV-2 PROTEASES WITH ENGINEERED AMINO-ACID SUBSTITUTIONS

被引:0
作者
ROSE, JR
SALTO, R
CRAIK, CS
机构
[1] UNIV CALIF SAN FRANCISCO, DEPT PHARMACEUT CHEM, SAN FRANCISCO, CA 94143 USA
[2] UNIV CALIF SAN FRANCISCO, DEPT PHARMACOL, SAN FRANCISCO, CA 94143 USA
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Autoproteolysis of the retroviral aspartyl proteases is a major obstacle to purification and analysis of these enzymes. A mutagenic approach to rendering autolytic cleavage sites less labile was applied to the primary. cleavage site between Leu5 and Trp6 in human immunodeficiency virus-1 (HIV-1) protease. From predictions based on known substrates it was concluded that amino acids Lys or Ser in place of Gln at position 7 would prevent cleavage at the Leu5-Trp6 peptide bond, therefore stabilizing the protein. Autoproteolytic stability was enhanced at least 100-fold by these mutations. At longer time points the protease was degraded at secondary sites which contained adequate substrate sequences but were conformationally restricted. Conversely, a mutation in HIV-2 protease which changed Lys7 to Gln rendered the protein 3-fold less stable and shifted the position of the initial autoproteolytic cleavage from Phe3-Ser4 to Leu5-Trp6. The effects of these mutations demonstrate that small changes in protein sequence can have a major impact on their autoproteolytic stability. The work described here suggests a general method for stabilizing proteases and perhaps other recombinantly produced proteins to autolysis.
引用
收藏
页码:11939 / 11945
页数:7
相关论文
共 27 条
  • [11] KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367
  • [12] MUTATIONAL ANALYSIS OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 PROTEASE SUGGESTS FUNCTIONAL HOMOLOGY WITH ASPARTIC PROTEINASES
    LOEB, DD
    HUTCHISON, CA
    EDGELL, MH
    FARMERIE, WG
    SWANSTROM, R
    [J]. JOURNAL OF VIROLOGY, 1989, 63 (01) : 111 - 121
  • [13] SUBSTITUTIONS AT THE P2' SITE OF GAG P17-P24 AFFECT CLEAVAGE EFFICIENCY BY HIV-1 PROTEASE
    MARGOLIN, N
    HEATH, W
    OSBORNE, E
    LAI, M
    VLAHOS, C
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 167 (02) : 554 - 560
  • [14] HUMAN IMMUNODEFICIENCY VIRUS-1 PROTEASE EXPRESSED IN ESCHERICHIA-COLI BEHAVES AS A DIMERIC ASPARTIC PROTEASE
    MEEK, TD
    DAYTON, BD
    METCALF, BW
    DREYER, GB
    STRICKLER, JE
    GORNIAK, JG
    ROSENBERG, M
    MOORE, ML
    MAGAARD, VW
    DEBOUCK, C
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (06) : 1841 - 1845
  • [15] MUCHMORE DC, 1989, METHOD ENZYMOL, V177, P44
  • [16] 3-DIMENSIONAL STRUCTURE OF ASPARTYL PROTEASE FROM HUMAN IMMUNODEFICIENCY VIRUS HIV-1
    NAVIA, MA
    FITZGERALD, PMD
    MCKEEVER, BM
    LEU, CT
    HEIMBACH, JC
    HERBER, WK
    SIGAL, IS
    DARKE, PL
    SPRINGER, JP
    [J]. NATURE, 1989, 337 (6208) : 615 - 620
  • [17] NORTH MJ, 1989, PROTEOLYTIC ENZYMES, P1105
  • [18] MUTATIONAL ANALYSIS OF A NATIVE SUBSTRATE OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEINASE
    PARTIN, K
    KRAUSSLICH, HG
    EHRLICH, L
    WIMMER, E
    CARTER, C
    [J]. JOURNAL OF VIROLOGY, 1990, 64 (08) : 3938 - 3947
  • [19] PICHUANTES S, 1990, J BIOL CHEM, V265, P13890
  • [20] RECOMBINANT HIV1 PROTEASE SECRETED BY SACCHAROMYCES-CEREVISIAE CORRECTLY PROCESSES MYRISTYLATED GAG POLYPROTEIN
    PICHUANTES, S
    BABE, LM
    BARR, PJ
    CRAIK, CS
    [J]. PROTEINS-STRUCTURE FUNCTION AND GENETICS, 1989, 6 (03): : 324 - 337